Gene Editing for Gene Therapies with 3D BioPrinting | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

Gene Editing for Gene Therapies with 3D BioPrinting

BioMEMS

THURSDAY Presentations on BioMEMS

‘Early identification of biomarkers for the delivery of personalised therapy’

Date	AM EST Time	Name	Topic
1/7/16	9:30	Dr. Pearlman	Medical Implants and Surgery
1/7/16	10:30	Dr. Irina	Engineering Tissue, Cell tissue engineering with BioMEMS
1/14/16	9:30	Dr. Evelina Cohn	“Promising molecules for cell detection in environmental and clinical samples:DNA/peptide co-assembly”
1/21/16	9:30	Aviva & Gerard	Oligonucleotide chips
1/28/16	9:30	Dr. CodringtonDr. Williams	APSTutorial on using WordPress on our Platform
2/4/16	9:30	Dr. Stu Cantor	6 Bio-MEMS in medical implants and surgery
			6.1 Implantable microelectrodes
			6.2 Microtools for surgery
			6.3 Drug delivery
2/11/16	No Meeting
2/18/16	9:30	Dr. WilliamsBill Zurn	BioMems cell signaling PCR, micro arrays and beyondMedical MEMS
2/25/16	9:30	Dr. Williams
	10:30	Dr. Danut Dragoi	BioMEMS based Optical Sensors
3/3/16	9:30	Dr. Codrington	‘Early identification of biomarkers for the delivery of personalised therapy’
10-Mar	9:30	Dr. Nir	TBA
3/17/16	9:30	Dr. Tilda	TBA
24-Mar	9:30	TBA	TBA
31-Mar	9:30		TBA

Oglionucleotides Chips

Gene Editing: The Role of Oligonucleotide Chips

Curators: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/01/07/gene-editing-the-role-of-oligonucleotide-chips/

Transposons

Advertisements

Advertisements

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,430 other followers
Recent Posts
- Digital Therapeutics: A threat or opportunity to pharmaceuticals March 18, 2019
- Immunoediting can be a constant defense in the cancer landscape March 16, 2019
- Immunotherapy may help in glioblastoma survival March 16, 2019
- 2018 CEO’s Compensation in Health Companies – Highest $99 Million to mid range $20 Million March 14, 2019
- Lesson 5 Cell Signaling And Motility: Cytoskeleton & Actin: Curations and Articles of reference as supplemental information: #TUBiol3373 March 13, 2019
- 2019 Koch Institute Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PMET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA March 12, 2019
- Mitralign and Corvia, Tewksbury, Mass – Investment and Acquisition by Edwards Lifesciences March 11, 2019
- VIDEOS: Artificial Intelligence Applications for Cardiology March 11, 2019
- At California Central District Court Juno Therapeutics, Inc. et al v. Kite Pharma, Inc. – Multi-party Patent Infringement March 11, 2019
- Tips on 280 Character Tweets on Twitter.com March 10, 2019
Archives
Archives
Categories
Categories
Meta

Advertisements